Literature DB >> 17452702

Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments.

Sunghyuk Choi1, Doyoung Park, Sungwoo Lee, Yunsik Hong, Sujin Kim, Jaekwan Lee.   

Abstract

OBJECTIVES: To determine the optimal cut-off values of B-type natriuretic peptide (BNP) for the diagnosis of congestive heart failure (CHF) in 1040 Korean patients with dyspnoea visiting emergency departments.
METHODS: BNP values were measured for 662 patients without CHF to examine whether significant relationships existed between the BNP values and age, gender or underlying disease. In 378 patients with CHF, a similar analysis was performed in addition to the examination of the relationship between the mean BNP values and CHF severity.
RESULTS: The optimal threshold for the detection of heart failure was a BNP concentration of 296.5 pg/mL, regardless of age, sex and underlying disease among the Korean study population. In the non-CHF patients, women showed significantly higher mean BNP values than did men. Further, in these patients, the mean BNP values of men with underlying disease (hypertension, angina pectoris, chronic renal failure, chronic obstructive pulmonary disease) and those with at least two underlying diseases, one of which was hypertension, was higher than those without underlying disease, whereas no difference was observed between women with and without underlying disease. Based on the New York Heart Association classification, echocardiography findings and mortality rate of the CHF patients, the BNP value was found to be related to both the severity of heart failure and its prognosis.
CONCLUSIONS: The BNP concentration used for the diagnosis of CHF in Korean people is considerably higher than the normal cut-off value of 100 pg/mL. In the non-CHF patients, the BNP values of women were influenced less by underlying disease. This suggests that the factors that influence BNP values in women are different from those in men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452702      PMCID: PMC2658481          DOI: 10.1136/emj.2006.041368

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  20 in total

1.  N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.

Authors:  Xiaomin Shi; Guobing Xu; Tiean Xia; Yixin Song; Qing Lin
Journal:  Clin Chim Acta       Date:  2005-10       Impact factor: 3.786

2.  Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.

Authors:  M Nakamura; H Endo; M Nasu; N Arakawa; T Segawa; K Hiramori
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 3.  Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus.

Authors:  S Cosson
Journal:  Diabetes Metab       Date:  2004-09       Impact factor: 6.041

Review 4.  The endocrine function of the heart.

Authors:  Monica Forero McGrath; Mercedes L Kuroski de Bold; Adolfo J de Bold
Journal:  Trends Endocrinol Metab       Date:  2005-11-02       Impact factor: 12.015

5.  Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.

Authors:  W H Wilson Tang; Kiran Philip; Stanley L Hazen; Cindy E Stevenson; Michael Pepoy; Sarah Neale; Gary S Francis; Frederick Van Lente; Andrew Smith; Alan H B Wu
Journal:  Clin Cornerstone       Date:  2005

6.  What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?

Authors:  H Kanda; Y Kita; T Okamura; T Kadowaki; Y Yoshida; Y Nakamura; H Ueshima
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

7.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

8.  The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure.

Authors:  Stefan Krüger; Jürgen Graf; Marc W Merx; Tina Stickel; Dagmar Kunz; Karl Christian Koch; Peter Hanrath; Uwe Janssens
Journal:  Eur J Intern Med       Date:  2006-03       Impact factor: 4.487

Review 9.  B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians.

Authors:  Roberto Cardarelli; Tomas G Lumicao
Journal:  J Am Board Fam Pract       Date:  2003 Jul-Aug

10.  Influence of imprecision on ROC curve analysis for cardiac markers.

Authors:  Peter Kupchak; Alan H B Wu; Farooq Ghani; L Kristen Newby; E Magnus Ohman; Robert H Christenson
Journal:  Clin Chem       Date:  2006-02-09       Impact factor: 8.327

View more
  4 in total

Review 1.  Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Authors:  Stephen A Hill; Ronald A Booth; P Lina Santaguida; Andrew Don-Wauchope; Judy A Brown; Mark Oremus; Usman Ali; Amy Bustamam; Nazmul Sohel; Robert McKelvie; Cynthia Balion; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Brain natriuretic peptide in the evaluation of emergency department dyspnea: is there a role?

Authors:  Christopher R Carpenter; Samuel M Keim; Andrew Worster; Peter Rosen
Journal:  J Emerg Med       Date:  2011-11-26       Impact factor: 1.484

3.  Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Authors:  Ronald A Booth; Stephen A Hill; Andrew Don-Wauchope; P Lina Santaguida; Mark Oremus; Robert McKelvie; Cynthia Balion; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

4.  SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.

Authors:  Edin Begic; Suncica Hadzidedic; Ajla Kulaglic; Belma Ramic-Brkic; Zijo Begic; Mirsada Causevic
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.